Skip to main content

Published locations for FDA approves nintedanib for scleroderma interstitial lung disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves nintedanib for scleroderma interstitial lung disease

User login

  • Reset your password
  • /content/fda-approves-nintedanib-scleroderma-interstitial-lung-disease
  • /edermatologynews/article/207728/lupus-connective-tissue-diseases/fda-approves-nintedanib-scleroderma
  • /rheumatologynews/article/207728/lupus-connective-tissue-diseases/fda-approves-nintedanib-scleroderma
  • /jcomjournal/article/207728/lupus-connective-tissue-diseases/fda-approves-nintedanib-scleroderma
  • /rheumatology/article/207728/lupus-connective-tissue-diseases/fda-approves-nintedanib-scleroderma
  • /dermatology/article/207728/lupus-connective-tissue-diseases/fda-approves-nintedanib-scleroderma
  • /chestphysician/article/207728/lupus-connective-tissue-diseases/fda-approves-nintedanib-scleroderma